Evidence map›Paper›PMID 40050865›Full record

ArticleJournal of nanobiotechnology2025

Atomically-precise Au

Elham Zeinizade, Goonay Yousefalizideh, Parimah Aminfar, Matthew Horn, Lili Ding, Layla Pires, Alina Jaglanian, Lucie Malbeteau, Kristen Harrington, Carla Calçada and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Elham ZeinizadePrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Goonay YousefalizidehDepartment of Chemistry, Queen's University, Kingston, ON, K7L 3N6, Canada.
Parimah AminfarDepartment of Chemistry, Queen's University, Kingston, ON, K7L 3N6, Canada.
Matthew HornPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Lili DingPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Layla PiresPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Alina JaglanianPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Lucie MalbeteauPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Kristen HarringtonDepartment of Chemistry, Queen's University, Kingston, ON, K7L 3N6, Canada.
Carla CalçadaPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Mohamad DukurayPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Brian C WilsonPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Marianne KoritzinskyPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Juan ChenPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada. juan.chen@uhn.ca.
Kevin G StamplecoskieDepartment of Chemistry, Queen's University, Kingston, ON, K7L 3N6, Canada. kevin.stamplecoskie@queensu.ca.
Gang ZhengPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada. gang.zheng@uhn.ca.

Funding

New Frontiers in Research Program NFRFT-2020-00573
6 · The paper itself

Abstract

Radiotherapy is a leading method for cancer treatment, effectively eliminating cancer cells but often causing collateral damage to surrounding healthy tissue. Radiosensitizers aim to enhance the therapeutic effects of radiotherapy while minimizing harm to normal cells. We recently reported atomically-precise gold nanoclusters, Au

Indexed as

GoldMetal NanoparticlesRadiation-Sensitizing AgentsAnimalsCell Line, TumorDNA DamageFemaleHumansMiceMice, Inbred BALB CTissue DistributionGoldRadiation-Sensitizing AgentsAtomically preciseBiocompatibilityCancer radiation therapyGold nanoclustersRadiosensitizerRenal clearanceUltra small size

Identifiers

PMID40050865
PMCPMC11887354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.